PortfoliosLab logoPortfoliosLab logo
ABBV vs. UVV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ABBV vs. UVV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and Universal Corporation (UVV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABBV achieves a 12.42% return, which is significantly higher than UVV's 4.70% return. Over the past 10 years, ABBV has outperformed UVV with an annualized return of 18.94%, while UVV has yielded a comparatively lower 4.42% annualized return.


ABBV

1D
-2.51%
1M
0.66%
6M
14.27%
YTD
12.42%
1Y
36.88%
3Y*
23.28%
5Y*
20.99%
10Y*
18.94%
ALL TIME*
20.35%

UVV

1D
-1.09%
1M
2.82%
6M
-3.87%
YTD
4.70%
1Y
2.97%
3Y*
8.03%
5Y*
6.52%
10Y*
4.42%
ALL TIME*
7.89%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.40B$1.53B$1.60B
$10.36M$11.73M$13.09M

ABBV vs. UVV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ABBV
AbbVie Inc.
12.42%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%
UVV
Universal Corporation
4.70%2.27%-13.39%35.79%1.82%19.59%-8.96%11.08%7.79%-14.79%

Correlation

The correlation between ABBV and UVV is 0.14, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.14

Correlation (3Y)
Balances recent behavior with more history.

0.20

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.23

Correlation (10Y)
Provides a long-term view across more market conditions.

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.22

Fundamentals

Market Cap

ABBV:

$443.24B

UVV:

$1.31B

EPS

ABBV:

$2.05

UVV:

$1.94

PE Ratio

ABBV:

122.29

UVV:

27.10

PS Ratio

ABBV:

7.08

UVV:

0.40

Total Revenue (TTM)

ABBV:

$62.82B

UVV:

$2.21B

Gross Profit (TTM)

ABBV:

$46.15B

UVV:

$412.39M

EBITDA (TTM)

ABBV:

$17.96B

UVV:

$212.91M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ABBV vs. UVV — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ABBV
ABBV Risk / Return Rank: 8181
Overall Rank
ABBV Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 8282
Sortino Ratio Rank
ABBV Omega Ratio Rank: 8080
Omega Ratio Rank
ABBV Calmar Ratio Rank: 8080
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7979
Martin Ratio Rank

UVV
UVV Risk / Return Rank: 4747
Overall Rank
UVV Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
UVV Sortino Ratio Rank: 4141
Sortino Ratio Rank
UVV Omega Ratio Rank: 4343
Omega Ratio Rank
UVV Calmar Ratio Rank: 5151
Calmar Ratio Rank
UVV Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ABBV vs. UVV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Universal Corporation (UVV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ABBVUVVDifference
Sharpe ratioReturn per unit of total volatility

+1.29

Sortino ratioReturn per unit of downside risk

+1.80

Omega ratioGain probability vs. loss probability

1.26

1.05

+0.22

Calmar ratioReturn relative to maximum drawdown

2.14

0.22

+1.92

Martin ratioReturn relative to average drawdown

4.73

0.43

+4.30

ABBV vs. UVV - Sharpe Ratio Comparison

The current ABBV Sharpe Ratio is 1.42, which is higher than the UVV Sharpe Ratio of 0.12. The chart below compares the historical Sharpe Ratios of ABBV and UVV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ABBV vs. UVV - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum UVV drawdown of -69.75%. Use the drawdown chart below to compare losses from any high point for ABBV and UVV.


Loading charts...

Drawdown Indicators


ABBVUVVDifference

Max Drawdown

Largest peak-to-trough decline

-45.09%

-69.75%

+24.66%

Max Drawdown (1Y)

Largest decline over 1 year

-17.32%

-13.48%

-3.84%

Max Drawdown (3Y)

Largest decline over 3 years

-20.74%

-29.70%

+8.96%

Max Drawdown (5Y)

Largest decline over 5 years

-21.92%

-29.70%

+7.78%

Max Drawdown (10Y)

Largest decline over 10 years

-45.09%

-45.68%

+0.59%

Current Drawdown

Current decline from peak

-4.69%

-13.00%

+8.31%

Average Drawdown

Average peak-to-trough decline

-10.64%

-18.57%

+7.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.81%

6.87%

+0.94%

Volatility

ABBV vs. UVV - Volatility Comparison

AbbVie Inc. (ABBV) has a higher volatility of 8.35% compared to Universal Corporation (UVV) at 7.36%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than UVV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABBVUVVDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.35%

7.36%

+0.99%

Volatility (6M)

Calculated over the trailing 6-month period

19.56%

19.86%

-0.30%

Volatility (1Y)

Calculated over the trailing 1-year period

26.14%

24.04%

+2.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.46%

24.67%

-1.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.92%

29.01%

-3.09%

Dividends

ABBV vs. UVV - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 2.72%, less than UVV's 6.24% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.72%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
UVV
Universal Corporation
6.24%6.18%5.87%4.72%5.95%5.64%6.30%5.29%4.80%4.11%3.33%3.71%

Financials

ABBV vs. UVV - Financials Comparison

This section allows you to compare key financial metrics between AbbVie Inc. and Universal Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


ABBV and UVV have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (8.35%) compared to UVV (7.36%). In terms of maximum drawdown, ABBV dropped -45.09% vs UVV's -69.75%.

ABBV currently has the higher Sharpe Ratio (1.42 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABBV and UVV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer